Medikamenteninduzierter Lupus erythematodes tumidus unter Adalimumab-Therapie

[1]  B. Zimmermann,et al.  Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents , 2008 .

[2]  B. Strober,et al.  From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. , 2008, Journal of the American Academy of Dermatology.

[3]  P. Baiardi,et al.  Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFα blocking agents in rheumatoid arthritis , 2007, Clinical Rheumatology.

[4]  K. Acland,et al.  Adalimumab‐induced cutaneous lupus , 2007, Clinical and experimental dermatology.

[5]  M. Khamashta,et al.  Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases , 2007, Medicine.

[6]  A. Spillane,et al.  Drug-induced lupus erythematosus in a patient treated with adalumimab. , 2007, Journal of the American Academy of Dermatology.

[7]  L. Truedsson,et al.  - 1-Predictors of infusion reactions during infliximab treatment in patients with arthritis , 2006 .

[8]  G. Burmester,et al.  Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis , 2005, Annals of the rheumatic diseases.

[9]  X. Mariette,et al.  Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey , 2005, Arthritis research & therapy.

[10]  N. Rothfield,et al.  Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[11]  Najia Shakoor,et al.  Drug-induced systemic lupus erythematosus associated with etanercept therapy , 2002, The Lancet.

[12]  P. Limburg,et al.  Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies. , 1996, Scandinavian journal of rheumatology.